FMR LLC 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-07 10:32 am Sale | 2026-04-30 | 13G | SOLENO THERAPEUTICS INC PA SLNO | FMR LLC | 193,014 0.400% | -5,575,396 (-96.65%) | Filing |
| 2026-05-06 11:43 am Sale | 2026-03-31 | 13G | SOLENO THERAPEUTICS INC PA SLNO | FMR LLC | 5,768,410 11.200% | -2,065,368 (-26.36%) | Filing |
| 2025-08-07 10:17 am Purchase | 2025-07-31 | 13G | SOLENO THERAPEUTICS INC PA SLNO | FMR LLC | 7,833,778 15.000% | 4,495,920 (+134.69%) | Filing |
| 2025-08-06 12:14 pm Purchase | 2025-06-30 | 13G | SOLENO THERAPEUTICS INC PA SLNO | FMR LLC | 3,337,858 6.600% | 3,337,858 (New Position) | Filing |